Organon divests JADA system to Laborie in $465m deal
Organon is selling its JADA post-partum haemorrhage (PPH) treatment system to Laborie Medical in a deal valued at up to…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
Nitinotes gains CE mark for endoscopic gastroplasty suturing platform
Israel-based Nitinotes Surgical has gained a CE mark for EndoZip, enabling the company to launch the automated suturing platform for…
-
BillionToOne raises $273.1m in IPO
BillionToOne has become a newly minted public company, raising $273.1m in an upsized initial public offering (IPO), despite the longest…
-
MMI wins IDE for surgical robotic Alzheimer’s disease study
US-based robotics company Medical Microinstruments (MMI) has obtained an investigational device exemption (IDE) from the US Food and Drug Administration…
-
Precision Neuroscience gains investment from paralysis-focused VC
Brain-computer interface (BCI) company Precision Neuroscience has received an investment from SCI Ventures, a VC firm that claims to hold…
-
Philips reiterates FY25 outlook following steady Q3 performance
Philips has maintained 2025 guidance after AI-powered innovation and sustained strength in the North American market powered Q3 comparable sales…
-
Sovato raises Series B funds to advance remote robotic surgery platform
Sovato has closed a Series B funding round to scale its remote robotic surgery (telesurgery) platform. Led by VC business…
-
Sofinnova spinoff Tulyp Medical emerges from stealth with perfusion tech
Tulyp Medical has emerged from stealth with its pressure-driven perfusion system for vascular procedures and submitted a 510(k) application with…
-
Pulsenmore stock up as at-home ultrasound secures FDA de novo authorisation
Pulsenmore’s at-home ultrasound platform, Pulsenmore ES, has received de novo authorisation from the US Food and Drug Administration (FDA). Pulsenmore…
-
FDA clears InterVene’s in-stent restenosis catheter
InterVene’s Recana, a mechanical thrombectomy catheter designed to address venous in-stent restenosis (ISR) and clear vessel obstructions, has received 510(k)…